Ungang, Trecy .
HRN: 23-64-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2023
CEFUROXIME 500MG (TAB)
08/31/2023
09/06/2023
ORAL
500mg
BID
UTI, Sp Nsvd
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes